Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivo

Thrombosis and Haemostasis

Volumn 89, Issue 6, 2003, Pages 1043-1051

  Clark, Peter ^a   Jordan, Fiona ^b   Pearson, Charles ^b   Walker, Isobel D ^b   Sattar, Naveed ^b   Ellison, Joanne ^b   Greer, Ian A ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

ICAM 1; Monocyte; Pregnancy; Thrombin

Indexed keywords

ACTIVATED PROTEIN C; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; THROMBIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; BLOOD GROUP; CELL COMPOSITION; CELL LINE; CLINICAL RESEARCH; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENZYME INDUCTION; FEMALE; FIBRINOGEN SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MONOCYTE; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; VASCULAR DISEASE;

EID: 0038150565     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613406     Document Type: Article

References (56)

1. Ott I, Andrassy M, Zieglgansberger D, et al. Regulation of monocyte procoagulant activity in acute myocardial infarction: Role of tissue factor and tissue factor pathway inhibitor-1. Blood 2001; 97: 3721-6.
2. Li A, Chang AC, Peer GT, et al. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes. Thromb Haemost 2001; 85: 830-6.
3. Ritchie H, Robbie LA, Kinghorn S, et al. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin. Thromb Haemost 1999; 81: 96-103.
4. Bar-Shavit R, Hruska KA, Kahn AJ, et al. Thrombin chemotactic stimulation of HL-60 cells: Studies on thrombin responsiveness as a function of differentiation. J Cell Physiol 1987; 131: 255-61.
5. Hoffman MC, Church F.C. Response of blood leukocytes to thrombin receptor peptides. J Leuk Biol 1993; 54: 145-51.
6. Ritchie HJ, Jamieson A, Booth NA. Thrombin modulates synthesis of plasminogen activator inhibitor type 2 by human peripheral blood monocytes. Blood 1995; 86: 3428-35.
7. Clark P, Brennand J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-70.
8. Clark P, Greer I, Walker I. Interaction of the protein C/protein S anticoagulant system, the endothelium and pregnancy. Blood Reviews 1999; 13: 127-46.
9. Dougherty GJ, Murdoch S, Hogg N. The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur J Immunol 1988; 18: 35-9.
10. Altieri DC, Duperray A, Plescia J, et al. Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem 1995; 270: 696-9.
11. Arefieva T, Krasnikova T. Monocyte cell adhesion to intact and plasmin-modified fibrinogen: Possible involvement of Mac-1 (CD11b/CD18) and ICAM-1 (CD54). J Cell Physiol 2001; 188: 403-9.
12. Herrick S, Blanc-Rude O, Gray A, et al. Fibrinogen. Int J Biochem 1999; 31: 741-6.
13. Smith E, Thompson W. Fibrin as a cofactor in atherogenesis. Thromb Res 1994; 73: 1-19.
14. Kaplanski G, Marin V, Fabrigoule M, et al. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 1998; 92: 1259-67.
15. Whincup P, Cook D, Phillips A, et al. ABO blood groups and ischaemic heart disease in British men. Br Med J 1990; 300: 1679-82.
16. Koster T, Blann AD, Briet E, et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
17. Graham I, Daly L, Refsum H, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775-81.
18. Clark P, Walker I. The phenomenon known as acquired APC resistance. Br J Haematol 2001; 115: 767-73.
19. Most J, Schwaeble W, Drach J, et al. Regulation of the expression of ICAM-1 on human monocytes and monocytic tumor cell lines. J Immunol 1992; 148: 1635-42.
20. Yamada A, Hara A, Inoue M, et al. Beta 2-integrin-mediated signal up-regulates counter-receptor ICAM-1 expression on human monocytic cell line THP-1 through tyrosine phosphorylation. Cell Immunol 1997; 178: 9-16.
21. Clark P, Sattar N, Walker I, Greer I. The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: Significance of pregnancy associated activated protein C resistance. Thromb Haemost 2001; 85: 30-5.
22. Lipid research clinics program. In: Manual of Laboratory Operations. Lipid and Lipoprotein Analysis. National Institute of Health. Bethseda, MD: DHEW Publications, NIH; 1975, 75.
23. Bernstein I, Self S. Joint report of the myeloid section of the Second International Workshop on human leukocyte differentiation antigens. Leucocyte Typing II: Human Myeloid and Haematopoietic Cells. In: Reinharz E, Haynes B, Nadler L, Bernstein I, eds. 1984, 31.
24. Johnson J, Shaw S. In: Knapp W, Dorken B, Gilks W, eds. Leucocyte Typing IV: White Cell Differentiation Antigens. Oxford: Oxford University Press; 1989, 681.
25. Maio M, Tessitori G, Pinto A, et al. Differential role of distinct determinants of intercellular adhesion molecule-1 in immunologic phenomena. J Immunol 1989; 143: 181-8.
26. Heinzelman M, Polk H, Chernobelsky A, et al. Endotoxin and muramyl dipeptide modulate surface receptor expression on human mononuclear cells. Immunopharmacology 2000; 48: 117-28.
27. Hailer NP, Glomsda B, Blaheta RA. Astrocytic factors down-regulate the expression of major histocompatibility complex-class-II and intercellular adhesion molecule-1 on human monocytes. Neuroscience Letters 2001; 298: 33-6.
28. Bernatchez S, Atkinson M, Parks P. Expression of intercellular adhesion molecule-1 on macrophages in vitro as a marker of activation. Biomaterials 1997; 18: 1371-8.
29. Hutchinson P, Kraft N, Atkins RC. Rapid induction of intercellular adhesion molecule-1 on monocytes and myelomonocytic cell lines after interferon gamma treatment. Transplantation 1992; 54: 671-6.
30. Simmons D, Makgoba MW, Seed B. ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature 1988; 331: 624-7.
31. Vassallo RR, Kieber-Emmons T, Cichowski K, et al. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem 1992; 267: 6081-5.
32. Brass LF, Pizarro S, Ahuja M, et al. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J Biol Chem 1994; 269: 2943-52.
33. Vu TKH, Hung DT, Wheaton VI, et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068.
34. Blann AD, Daly R, Amiral J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996; 92: 498-500.
35. Clark P, Walker I, Greer I. Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight. Lancet 1999; 353: 292-3.
36. Khong T, De Wolf F, Robertson W, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestation-age infants. Br J Obstet Gynaecol 1986; 93: 1049-59.
37. Doi H, Kugiyama K, Oka H, et al. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation 2000; 102: 670-6.
38. Ohta T, Saku K, Takata K, et al.. Soluble vascular cell-adhesion molecule-1 and soluble intercellular adhesion molecule-1 correlate with lipid and apolipoprotein risk factors for coronary artery disease in children. Eur J Pediat 1999; 158: 592-8.
39. Niwa ST, Totsuka T, Hayashi S. Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line. Int J Immunopharmacol 1996; 18: 669-75.
40. Bremme K, Ostlund E, Almqvist I, et al.. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynaecol 1992; 80: 132-7.
41. Shi-Wen X, Panesar M, Vancheeswaran R, et al.. Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis factor alpha, and estrogen. Arth Rheum 1994; 37: 1689-97.
42. Bellamy MF, McDowell IF. Putative mechanisms for vascular damage by homocysteine. J Inherit Metab Dis 1997; 20: 307-15.
43. Kyrle PA, Stumpflen A, Hirschl M, et al.. Levels of prothrombin fragment F1+2 is patients with hyperhomocysteinemia and a history of venous thrombosis. Thromb Haem 1997; 78: 1327-31.
44. Bruserud O, Akselen PE, Bergheim J, et al.. Serum concentrations of E-selectin, P-selectin, ICAM-1 and interleukin 6 in acute leukaemia patients with chemotherapy-induced leucopenia and bacterial infections. Br J Haematol 1995; 91: 394-402.
45. Austgulen R, Lien E, Vince G, et al.. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 71: 53-8.
46. Krauss T, Kuhn W, Lakoma C, et al.. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 1997; 177: 443-9.
47. Krauss T, Emons G, Kuhn W, et al.. Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. Clin Chem 2002; 48: 1418-25.
48. Airoldi L, Gaffuri B, Rossi G, et al.. Soluble intercellular adhesion molecule-1 serum profile in physiologic and preeclamptic pregnancy. Am J Reprod Immunol 1998; 39: 183-8.
49. Phocas I, Rizos D, Papoulias J, et al.. A comparative study of serum soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 in preeclampsia. J Perinatol 2000; 20: 114-9.
50. Djurovic S, Schjetlein R, Wisloff F, et al.. Increased levels of intercellular adhesion molecules and vascular cell adhesion molecules in pre-eclampsia. Br J Obstet Gynaecol 1997; 104: 466-70.
51. Pigott RD, Dillon LP, Hemingway IH, et al.. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187: 584-9.
52. Giavazzi R, Nicoletti MI, Chirivi RG, et al.. Soluble intercellular adhesion molecule-1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts. Eur J Cancer 1994; 30A: 1865-70.
53. Colotta F, Sciacca FL, Sironi M, et al.. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol 1994; 144: 975-85.
54. Naldini A, Carney DH, Bocci V, et al.. Thrombin enhances T cell proliferative responses and cytokine production. Cell Immunol 1993; 147: 367-77.
55. Languino L, Plescia J, Duperray A. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1 dependent pathway. Cell 1993; 73: 1423-34.
56. Wilczynski J, Banasik M, Tchorzewski H, et al.. Expression of intercellular adhesion molecule-1 on the surface of peripheral blood and decidual lymphocytes of women with pregnancy-induced hypertension. Eur J Obstet Gynecol Reprod Biol 2002; 102: 15-20.